Eden vs MEDGm for weight loss
Eden and MEDGm side by side: what each costs as your dose rises, which medications each prescribes, and the terms behind the price.
By the RxLineup editorial team · Fact-checked against provider sites and FDA labels · Updated
Only providers that pay us appear in our rankings and reviews, and we’re paid when you sign up through our links. How we make money
- Safety: GLP-1 medications carry a boxed warning for thyroid C-cell tumors. Read before you start
Higher score
Eden
Rated 9.1 out of 10, Excellent
From $99/mo
Tirzepatide $129/mo
MEDGm
Rated 9.0 out of 10, Excellent
From $299/mo
Tirzepatide $269/mo
The verdict
Eden charges less for compounded semaglutide ($99/mo vs $169/mo, 12 mo prepaid); Eden charges less for compounded tirzepatide ($129/mo vs $269/mo, 12 mo prepaid). Only Eden offers Mounjaro; only MEDGm offers oral compounded GLP-1 and the Wegovy pill. Eden scores higher overall (9.1 vs 9.0), with its widest lead on price and value (9.3 vs 8.0).
Choose Eden if…
You want compounded semaglutide for $99/mo, compounded tirzepatide for $129/mo and the option of Mounjaro.
Choose MEDGm if…
You want the option of oral compounded GLP-1 or the Wegovy pill and a better experience score (10.0 vs 9.0).
What’s different
The five places where Eden and MEDGm differ for weight loss, from the prices and terms each publishes.
| Difference | Eden | MEDGm |
|---|---|---|
| Compounded semaglutide | $99/mo | $169/mo |
| Compounded tirzepatide | $129/mo | $269/mo |
| Mounjaro | $1,498/mo | Not offered |
| Oral compounded GLP-1 | Not offered | $239/mo |
| Wegovy pill | Not offered | Offered; price not published |
Both offer Wegovy, Ozempic and Zepbound.
Head to head
| Feature | Eden review | MEDGm review |
|---|---|---|
| Overall score | 9.1/10 Higher | 9.0/10 |
| Starting price | $99/mo Lower | $299/mo |
| Compounded semaglutide | $99/mo Lower | $169/mo billed $2,028 for 12 months |
| Compounded tirzepatide | $129/mo Lower | $269/mo billed $3,228 for 12 months |
| Brand-name options | Wegovy, Ozempic, Zepbound, Mounjaro | Zepbound, Wegovy, Wegovy pill, Ozempic |
| Same price at every dose | Yes | Yes |
| Membership | None | None |
| Insurance | Self-pay | – |
| Refunds | Weight Loss Warranty: follow your Eden plan for 6 months and, if you lose less than 15% of your body weight, you may qualify for your money back. Eligibility depends on plan adherence and required check-ins | 100% refund if the provider determines you don’t qualify |
| Availability | – | All 50 states and DC (its terms say some medications may not be available in every state) |
| Next step | Visit Eden for Eden (opens in a new tab) | Visit MEDGm for MEDGm (opens in a new tab) |
– Not published by the provider.
Scores compared
Both programs are scored out of 10 on the same five weighted criteria. How we rate
EdenMEDGm
-
Price & value 30%
-
Clinical care 25%
-
Medication options 20%
-
Transparency 15%
-
Experience 10%
Eden pros and cons
Strengths
- $99/mo semaglutide and $129/mo tirzepatide at every dose
- No membership fee or long-term contract on GLP-1 plans
- Weight Loss Warranty, and labwork when a provider orders it
- LegitScript seal; HSA/FSA eligible; free expedited shipping
Drawbacks
- Brand-name GLP-1s cost $1,399 to $1,695 a month plus a $99 membership
- Charges are non-refundable once filled, apart from the warranty
- Partner pharmacies other than Eden Pharmacy aren’t named
- No state list published
MEDGm pros and cons
Strengths
- Lab work and metabolic report included
- Unlimited clinician access by video or chat
- Same price at any dose
- Compounded tablets plus brand-name Zepbound, Wegovy and Ozempic
- Pharmacies named; HSA/FSA eligible
Drawbacks
- Month to month is $299 for semaglutide after the first month
- No refund for the current month on monthly plans
- Brand-name medication prices not published
- Cancel at least 72 hours before renewal
Safety
One of these treatments carries an FDA boxed warning, the strongest warning on a label: GLP-1 medications.
- SemaglutideNot FDA-approved
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2. FDA label
- TirzepatideNot FDA-approved
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2. FDA label
- WegovyFDA-approved for long-term weight reduction (adults, and children 12 and older)
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
- OzempicFDA-approved drug; used off-label here
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
- ZepboundFDA-approved for long-term weight reduction (adults)
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
- MounjaroFDA-approved drug; used off-label here
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
- Compounded GLP-1sCompounded; not FDA-approved
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
- Wegovy pillFDA-approved for long-term weight reduction (adults)
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
Not medical advice. A licensed clinician decides whether a treatment is right for you; read the full prescribing information before you start.
Not sure which program fits?
Answer five quick questions about budget, medication and insurance, and we’ll rank the programs for you. No email or sign-up needed.